Moreover, one previous study shows that the protein expression of STAT3 is down-regulated in the patients with end-stage of DCM [9], while overexpression of STAT3 in the heart protects against doxorubicin-induced cardiomyopathy [10]. The gene discussed is STAT3; the disease is familial dilated cardiomyopathy.